Front Line Medical recently announced that it expanded the availability of its COBRA-OS aortic occlusion device to meet growing demands. The Ontario, Canada-based company is increasing production of the COBRA-OS (control of bleeding, resuscitation, arterial occlusion system) occluder following patient success rates and expanded interest from hospitals to treat trauma. Get the full story on […]
Front Line Medical Technologies
FDA clears Front Line Medical arterial occlusion system
Front Line Medical Technologies today announced that its COBRA-OS bleeding control device won FDA 510(k) clearance. The COBRA-OS (control of bleeding, resuscitation, arterial occlusion system) is a 4 French REBOA (resuscitative endovascular balloon occlusion of the aorta) device that provides full occlusion, intermittent occlusion or partial occlusion depending on a patient’s needs. Get the full story […]